These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5457931)

  • 1. Nucleophilic substitution on carcinogenic N-acetoxy-N-arylacetamides.
    Scribner JD; Miller JA; Miller EC
    Cancer Res; 1970 Jun; 30(6):1570-9. PubMed ID: 5457931
    [No Abstract]   [Full Text] [Related]  

  • 2. Reactions of esters of N-hydroxy-2-acetamidophenanthrene with cellular nucleophiles and the formation of free radicals upon decomposition of N-acetoxy-N-arylacetamides.
    Scribner JD; Naimy NK
    Cancer Res; 1973 Jun; 33(6):1159-64. PubMed ID: 4718667
    [No Abstract]   [Full Text] [Related]  

  • 3. The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.
    Yost Y; Gutmann HR; Rydell RE
    Cancer Res; 1975 Feb; 35(2):447-59. PubMed ID: 1109807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The activation of carcinogenic aromatic amines in metabolism].
    Neumann HG
    Klin Wochenschr; 1970 Aug; 48(16):959-66. PubMed ID: 4997044
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutations and loss of transforming activity of Bacillus subtilis DNA after reaction with esters of carcinogenic N-hydroxy aromatic amides.
    Maher VM; Miller JA; Miller EC; Summers WC
    Cancer Res; 1970 May; 30(5):1473-80. PubMed ID: 4987694
    [No Abstract]   [Full Text] [Related]  

  • 6. The conversion of noncarcinogenic aromatic amides to carcinogenic arylhydroxamic acids by synthetic N-hydroxylation.
    Gutmann HR; Galitski SB; Foley WA
    Cancer Res; 1967 Aug; 27(8):1443-55. PubMed ID: 6047873
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of action of carcinogenic aromatic amides.
    Gutmann HR; Barry EJ; Malejkagiganti D
    J Natl Cancer Inst; 1969 Jul; 43(1):287-91. PubMed ID: 5796392
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of liver regeneration on the loss of fluorenylacetamide derivative bound to liver DNA.
    Witschi H; Epstein SM; Farber E
    Cancer Res; 1971 Mar; 31(3):270-3. PubMed ID: 5547215
    [No Abstract]   [Full Text] [Related]  

  • 9. N-acetoxy-N-acetylaminoarenes and nitrosoarenes. One-electron non-enzymatic and enzymatic oxidation products of various carcinogenic aromatic acethydroxamic acids.
    Bartsch H; Miller JA; Miller EC
    Biochim Biophys Acta; 1972 Jun; 273(1):40-51. PubMed ID: 5038286
    [No Abstract]   [Full Text] [Related]  

  • 10. N-Hydroxylation and acetic acid hydroxylation of N-arylacetamides by rabbits.
    Fries W; Kiese M; Lenk W
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):327-8. PubMed ID: 4253768
    [No Abstract]   [Full Text] [Related]  

  • 11. The enzymatic reduction of the N-hydroxy derivatives of 2-acetylaminofluorene and related carcinogens by tissue preparations.
    Lotlikar PD; Miller EC; Miller JA; Margreth A
    Cancer Res; 1965 Nov; 25(10):1743-52. PubMed ID: 5892967
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of 3-methylcholanthrene and diet on the binding of 2-acetylaminofluroene and its N-hydroxy metabolite to rat liver nucleic acids.
    Irving CC; Peeler TC; Veazey RA; Wiseman R
    Cancer Res; 1971 Oct; 31(10):1468-72. PubMed ID: 5095133
    [No Abstract]   [Full Text] [Related]  

  • 13. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro.
    Gutmann HR; Erickson RR
    J Biol Chem; 1972 Feb; 247(3):660-6. PubMed ID: 5058220
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of N-hydroxy-2-acetylaminofluorene sulfotransferase activity in the mammary gland and Zymbal's gland of the rat.
    Irving CC; Janss DH; Russell LT
    Cancer Res; 1971 Apr; 31(4):387-91. PubMed ID: 5553685
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of carcinogenic arylhydroxamic acids by human tissues.
    King CM; Olive CW; Cardona RA
    J Natl Cancer Inst; 1975 Aug; 55(2):285-7. PubMed ID: 1159819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic activation of carcinogenic aromatic amines and amides.
    Miller JA; Miller EC
    Prog Exp Tumor Res; 1969; 11():273-301. PubMed ID: 4888944
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased selectivity of interaction between fluorenylamine carcinogens and liver proteins during hepatocarcinogenesis.
    Sorof S; Young EM; McBride RZ; Coffey CB; Luongo L
    Mol Pharmacol; 1969 Nov; 5(6):625-39. PubMed ID: 5373894
    [No Abstract]   [Full Text] [Related]  

  • 18. Acylation of carcinogenic aromatic hydroxamic acids by acetyl-CoA and carbamoyl phosphate to form reactive esters.
    Lotlikar PD
    Xenobiotica; 1971; 1(4):543-4. PubMed ID: 5164804
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: The metabolic activation of the double bond of carcinogenic stilbenes.
    Metzler M; Neumann HG
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R75. PubMed ID: 1143493
    [No Abstract]   [Full Text] [Related]  

  • 20. Unusual reactions of the model carcinogen N-acetoxy-N-acetyl-2-amino-alpha-carboline.
    Novak M; Nguyen TM
    J Org Chem; 2003 Dec; 68(26):9875-81. PubMed ID: 14682678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.